GTR 105744484
Tenders Are Invited For Antineoplastic And Immunomodulating Agents – Monoclonal Antibody - Daratumumab I.
ICB — International Competitive Bid
Closed
Eastern Europe
Tender Information
GTR Reference
105744484
Tendering Authority
Subscribe to view
Tender No
802986-2025
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Antineoplastic And Immunomodulating Agents – Monoclonal Antibody - Daratumumab I.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
European Union
Last Date of Bid Submission
08-01-2026
Closed
Work Detail
Antineoplastic And Immunomodulating Agents – Monoclonal Antibody - Daratumumab I.. The Subject Of The Public Contract Is The Supply Of A Medicinal Product For Parenteral Administration Containing The Monoclonal Antibody Igg1kappa Daratumumab (Atc Group L01fc01) For The Treatment Of Patients In Approved Indications According To The Spc Valid On The Date Of Submission Of Tenders And In Off-Label Administration After Prior Approval By The Reviewing Physician Of The Health Insurance Company.
Key Value
Tender Value
19,673,000 - CZK
Tender Documents
Global Tender Document
cf04ba81-54be-4fe9-be86-c9105e8b8195.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.